Chicago Equity Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | $4.67M | Sell |
19,630
-14,340
| -42% | -$3.41M | 0.47% | 34 |
|
|
2019
Q4 | $7.44M | Sell |
33,970
-17,240
| -34% | -$3.77M | 0.43% | 31 |
|
|
2019
Q3 | $8.68M | Buy |
51,210
+305
| +0.6% | +$51.7K | 0.41% | 42 |
|
|
2019
Q2 | $9.34M | Sell |
50,905
-11,395
| -18% | -$2.09M | 0.42% | 45 |
|
|
2019
Q1 | $11.5M | Buy |
62,300
+43,490
| +231% | +$8M | 0.44% | 42 |
|
|
2018
Q4 | $3.12M | Sell |
18,810
-5,030
| -21% | -$834K | 0.13% | 230 |
|
|
2018
Q3 | $4.6M | Sell |
23,840
-6,230
| -21% | -$1.2M | 0.14% | 199 |
|
|
2018
Q2 | $5.11M | Buy |
30,070
+27,015
| +884% | +$4.59M | 0.16% | 180 |
|
|
2018
Q1 | $498K | Buy |
+3,055
| New | +$498K | 0.02% | 609 |
|
|
2017
Q4 | – | Sell |
-4,180
| Closed | -$636K | – | 839 |
|
|
2017
Q3 | $636K | Buy |
+4,180
| New | +$636K | 0.02% | 586 |
|